Here we describe a protocol for the generation of cationic nanoliposomes, which is based on the dry-film method and can be used for the safe and efficient delivery of in vitro transcribed messenger RNA.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
Here we describe a protocol for the generation of cationic nanoliposomes, which is based on the dry-film method and can be used for the safe and efficient delivery of in vitro transcribed messenger RNA.
The development of messenger RNA (mRNA)-based therapeutics for the treatment of various diseases becomes more and more important because of the positive properties of in vitro transcribed (IVT) mRNA. With the help of IVT mRNA, the de novo synthesis of a desired protein can be induced without changing the physiological state of the target cell. Moreover, protein biosynthesis can be precisely controlled due to the transient effect of IVT mRNA.
For the efficient transfection of cells, nanoliposomes (NLps) may represent a safe and efficient delivery vehicle for therapeutic mRNA. This study describes a protocol to generate safe and efficient cationic NLps consisting of DC-cholesterol and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) as a delivery vector for IVT mRNA. NLps having a defined size, a homogeneous distribution, and a high complexation capacity, and can be produced using the dry-film method. Moreover, we present different test systems to analyze their complexation and transfection efficacies using synthetic enhanced green fluorescent protein (eGFP) mRNA, as well as their effect on cell viability. Overall, the presented protocol provides an effective and safe approach for mRNA complexation, which may advance and improve the administration of therapeutic mRNA.
The use of modified mRNA for therapeutic applications has shown great potential in the last couple of years. In cardiovascular, inflammatory, and monogenetic diseases, as well as in developing vaccines, mRNA is a promising therapeutic agent1.
Protein replacement therapy with mRNA offers several advantages over the classical gene therapy, which is based on DNA transfection into the target cells2. The mRNA function initiates directly in the cytosol. Although the plasmid DNA (pDNA), a construct of double-stranded, circular DNA containing a promoter region and a gene sequence encoding the therapeu....
Access restricted. Please log in or start a trial to view this content.
1. Generation of Cationic Nanoliposomes (Figure 1)
Access restricted. Please log in or start a trial to view this content.
Using the protocol as described, NLps consisting of the lipids DC-cholesterol and DOPE were prepared using the dry-film method (Figure 1). During the preparation, the nanoliposome solution shows different stages in turbidity (Figure 2).
The encapsulation efficacy of the NLps can then be analyzed after the encapsulation of 1 µg of eGFP-encoding mRNA by analyzing the free.......
Access restricted. Please log in or start a trial to view this content.
The presented protocol describes the generation of NLps with high encapsulation efficacy for synthetically modified mRNA, as well as the reliable transfection of cells in vitro. Moreover, the NLps guarantee the release of mRNA, which in turn, is translated into a functional protein inside the cells. Additionally, the transfections using NLps can be performed in regular cell medium, resulting in high cell viabilities during transfection, and last up to three days after transfection.
To.......
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) | AppliChem, Darmstadt, Germany | A2231 | |
| (3β-[N-(N′,N′-dimethylaminoethane)-carbamoyl]cholesterol hydrochloride (DC-Cholesterol) | Avanti, Alabama, USA | 700001 | |
| 4 ′,6-diamidino-2-phenylindole (DAPI) | Thermo Fisher Scientific, Darmstadt, Germany | D1306 | |
| BD FACScan system | BD Biosciences, Heidelberg, Germany | ||
| Cell Fix (10x) | BD Biosciences, Heidelberg, Germany | 340181 | |
| Chloroform | Merck, Darmstadt, Germany | 102445 | |
| Dimethyl sulfoxid (DMSO) | Serva Electrophoresis GmbH, Heidelberg, Germany | 20385.02 | |
| Dioleoyl phosphatidylethanolamine (DOPE) | Avanti, Alabama, USA | 850725 | |
| Fluorescence microscope | Zeiss Axio, Oberkochen, Germany | ||
| Lipofectamine 2000 | Thermo Fisher Scientific, Darmstadt, Germany | 11668019 | |
| Mini extruder | Avanti, Alabama, USA | ||
| Nuclease-free water | Qiagen, Hilden, Germany | 129114 | |
| Opti-Mem | Thermo Fisher Scientific, Darmstadt, Germany | 11058021 | |
| PBS buffer (w/o Ca2+/Mg2+) | Thermo Fisher Scientific, Darmstadt, Germany | 70011044 | |
| Quant-iT Ribo Green RNA reagent kit | Thermo Fisher Scientific, Darmstadt, Germany | Q33140 | |
| RPMI (w/o phenol red) | Thermo Fisher Scientific, Darmstadt, Germany | 11835030 | |
| Silica gel | Carl Roth, Karlsruhe, Germany | P077 | |
| Trypsin/EDTA (0.05%) | Thermo Fisher Scientific, Darmstadt, Germany | 25300054 | |
| HotStar HiFidelity Polymerase Kit | Qiagen, Hilden, Germany | 202602 | |
| QIAquick PCR Purification Kit | Qiagen, Hilden, Germany | 28104 | |
Pseudouridine-5'-Triphosphate (Ψ-UTP) | TriLink Biotechnologies, San Diego, USA | N-1019 | |
| 5-Methylcytidine-5'-Triphosphate (Methyl-CTP) | TriLink Biotechnologies, San Diego, USA | N-1014 | |
| Cyanine 3-CTP | PerkinElmer, Baesweiler, Germany | NEL580001EA | |
| RNeasy Mini Kit | Qiagen, Hilden, Germany | 74104 | |
| MEGAscript T7 Transcription Kit | Thermo Fisher Scientific, Darmstadt, Germany | AM1333 | |
| 3´-O-Me-m7G(5')ppp(5')G RNA Cap Structure Analog | New England Biolabs, Ipswich, USA | S1411L | |
| Antarctic Phosphatase | New England Biolabs, Ipswich, USA | M0289S | |
| Agarose | Thermo Fisher Scientific, Darmstadt, Germany | 16500-500 | |
| GelRed | Biotium, Fremont, USA | 41003 | |
| peqGOLD DNA ladder mix | VWR, Pennsylvania, USA | 25-2040 | |
| Invitrogen 0.5-10kb RNA ladder | Fisher Scientific, Göteborg, Sweden | 11528766 |
Access restricted. Please log in or start a trial to view this content.